Candriam SCA’s Orthofix Medical OFIX Stock Holding History

Candriam SCA’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12,612	Closed	-$690K	–	780
2017 Q4	$690K	Buy	12,612 +4,755	+61%	+$247K	0.01%	638
2017 Q3	$371K	Buy	+7,857	New	+$370K	0.01%	689

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Candriam SCA's OFIX Position: Q1 2018 in Review

Candriam SCA sold out of Orthofix Medical (OFIX) in Q1 2018, closing a stake of 12,612 shares — an estimated $690K sold.

Candriam SCA first reported a position in OFIX in Q3 2017 and held it in 2 quarters. The position peaked at $690K in Q4 2017. 178 funds tracked by Wall St. Rank hold OFIX as of Q1 2018.

Candriam SCA reported no remaining Orthofix Medical position as of Q1 2018 after selling out during the quarter.
Candriam SCA sold 12,612 Orthofix Medical shares in Q1 2018, an estimated $690K.
Candriam SCA first reported a position in Orthofix Medical in Q3 2017 and held it in 2 quarters.
Candriam SCA's Orthofix Medical position peaked at $690K in Q4 2017.
178 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2018.

Based on Candriam SCA's 13F filing for Q1 2018, filed 9 May 2018.